NCT05406752View on ClinicalTrials.gov

Pharmacokinetic Study of Paracetamol UNIFLASH (125 MG/1.25 ML)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 22, 2022

Primary Completion Date

July 23, 2022

Study Completion Date

July 23, 2022

Conditions
Acute Pain
Interventions
DRUG

paracetamol Uniflash (125 mg/ 1.25 mL)

Oromucosal solution (125 mg/ 1.25 mL) for buccal route

Trial Locations (1)

400710

Raptim Research Pvt. Ltd., Navi Mumbai

All Listed Sponsors
collaborator

Raptim Research

OTHER

lead

Unither Pharmaceuticals, France

INDUSTRY